BSE filing, NSE: YATHARTH. Summary written from the filing by ALFA Finder's alert engine.
Yatharth Hospital & Trauma Care Services Ltd: key numbers
- Share price
- ₹944.00
- Market cap
- ₹9,096 Cr
- Revenue (annual)
- ₹1,207 Cr
- Net profit (annual)
- ₹175.4 Cr
- P/E (TTM)
- 50.2×Sector 51.1×
- Promoter holding
- 55.80%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yatharth Hospital & Trauma Care Services Ltd
All →Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital & Trauma Care Services Ltd announced the voting results for its Extraordinary General Meeting held on October 15, 2026, where all five resolutions passed.
Yatharth Hospital & Trauma Care Services Preferential Issue
Yatharth Hospital's EGM approved increasing authorized share capital, issuing subscription securities (equity shares and warrants) via preferential placement, and amending articles of association.
Yatharth Hospital & Trauma Care Services Other Announcement
Yatharth Hospital & Trauma Care Services Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital & Trauma Care Services issued a corrigendum to the EGM notice dated September 22, 2026, regarding its proposed preferential issue of equity shares and warrants.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital issued an EGM notice for October 15, 2026. Agenda items include a preferential issue and authorized capital increase.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital convened an EGM to approve increasing its authorized share capital and a preferential issue of equity shares and warrants aggregating to ₹1,283.33 Crore.
- Value
- ₹1,283 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.